in

Johnson & Johnson to begin human trials for coronavirus vaccine in late July, earlier than expected

J&J said it is committed to the goal of supplying more than 1 billion doses globally through the course of 2021.

Source: Business - cnbc.com

Dow futures fall more than 100 points following two days of losses

Tesla Stock Soars Above $1,000, Surpassing Bitcoin’s Market Cap